GGrantIndex
Sort

261,768 grants matching gene therapy

A Pharmacochaperone-based strategy for identifying chemical probes of brain-derived orphan GPCRs

$907,259
Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · MH

Specific Adoptive Immunotherapy of AML with Engineered CD8+ T Cells

$907,233
Philip D Greenberg · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA

In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles

$907,227
Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2023 · AI

Mapping Drug Resistance Genes in Plasmodium falciparum

$907,161
Tim J Anderson · Texas Biomedical Research Institute · R01 · FY2024 · AI

Clinical Trials Engine Lentiviral engineered T cells for HIV

$907,100
Carl H. June · University Of Pennsylvania · U19 · FY2007 · AI

STING agonist-expressing BCG for bladder cancer

$907,018
Todd Wallach · Oncosting Llc · R44 · FY2022 · CA

Multicellular Mechanisms Driving Axon Regeneration

$907,016
Valeria Cavalli · Washington University · R35 · FY2025 · NS

Cancer immunotherapy

$906,886
Eytan Ruppin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Tissue Processing-Sequencing Facility

$906,825
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Optimizing AAV delivery of bNAbs for HIV prevention

$906,720
Matthew Ryan Gardner · Emory University · R01 · FY2022 · AI

Therapeutic Inhibition of MYC:TRRAP Interaction in Cancer

$906,627
Ed Feris · Cosmyc Inc · R44 · FY2025 · CA

Effect of opioid use disorder on HIV latent reservoirs and immune dysfunction assessed by single-cell transcriptomics

$906,620
Christine Cheng · Boston University (Charles River Campus) · R33 · FY2022 · DA

Novel Mutations and Therapy Resistance Mechanisms in Pediatric Cancers

$906,517
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma

$906,517
Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

National Gene Vector Biorepository and Coordinating Center at Indiana University

$906,475
Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2013 · HL

Regulatory T cells and the tumor microenvironment

$906,382
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R35 · FY2022 · CA

Regulatory T cells and the tumor microenvironment

$906,381
Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R35 · FY2023 · CA

Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection

$906,325
Larry S. Schlesinger · Texas Biomedical Research Institute · R01 · FY2025 · AI

Targeting PD-1 Pathway for Functional Cure of AIDS

$906,321
Rama Rao Amara · Emory University · R37 · FY2014 · AI

Studying factors controlling cancer progression and immune recognition in mouse models

$906,300
Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2024 · CA

Nonhuman Primate Core

$906,156
Hans-Peter Kiem · University Of California Los Angeles · U19 · FY2022 · AI

Dissecting Co-Dependent Pathways in Oral Cancers

$906,134
Thomas E. Carey · University Of Michigan At Ann Arbor · U01 · FY2015 · DE

Intracellular Innate Immune Receptors in Cancer Suppression and Immunotherapy

$906,118
Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R35 · FY2023 · CA

PRECLINICAL MOUSE: CENTRAL NERVOUS SYSTEM CANCERS

$906,052
University Of North Carolina Chapel Hill · U01 · FY2001 · CA

Enhanced latency reversal and reservoir clearance in macaques

$906,012
Ann M Chahroudi · Emory University · R37 · FY2022 · AI